Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ITOC 2015 /
Immuno-oncology: Changing the landscape of cancer therapy

25th - 27th Mar 2015

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 19.05.15
Views: 2692

Prof Peter Johnson - University of Southampton, Southampton, UK

Professor Johnson speaks about agents designed to directly harness the patient’s own immune system to fight cancer.

This mechanism, in theory, offers the potential for activity across cancer types.

Based on successes in melanoma and NSCLC with immuno-oncology agents, he speaks about how they are now under evaluation in virtually every type of cancer.

Wide ranging research efforts are ongoing to explore how to improve outcomes with these agents and identify new approaches to therapy, with hopes that in the forthcoming years we could see immuno-oncology transforming the treatment of a range of different types of cancer.

See also:

PD-1 inhibition in lung cancer: Paving the way for a brighter future

Raising the bar in melanoma treatment with immuno-oncology

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation